+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transcatheter Heart Valves - Medical Devices Pipeline Product Landscape, 2021

  • ID: 5517730
  • Report
  • December 2021
  • Region: Global
  • 343 Pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • 3DT Holdings LLC
  • CardioMech AS
  • HighLife SAS
  • Mitralix Ltd.
  • Peijia Medical Ltd
  • Trisol Medical Ltd
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Transcatheter Heart Valves - Medical Devices Pipeline Product Landscape, 2021

Summary


the publisher's Medical Devices sector report, “Transcatheter Heart Valves - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Transcatheter Heart Valves pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Transcatheter heart valves are synthetic valves made from biological tissues surrounded by a steel, cobalt-chromium, or nitinol stent. These valves can be either balloon expandable or self-expandable.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope


– Extensive coverage of the Transcatheter Heart Valves under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Transcatheter Heart Valves and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to Buy


The report enables you to -
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
– Identify and understand important and diverse types of Transcatheter Heart Valves under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3DT Holdings LLC
  • CardioMech AS
  • HighLife SAS
  • Mitralix Ltd.
  • Peijia Medical Ltd
  • Trisol Medical Ltd
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Transcatheter Heart Valves Overview

3 Products under Development
3.1 Transcatheter Heart Valves - Pipeline Products by Stage of Development
3.2 Transcatheter Heart Valves - Pipeline Products by Segment
3.3 Transcatheter Heart Valves - Pipeline Products by Territory
3.4 Transcatheter Heart Valves - Pipeline Products by Regulatory Path
3.5 Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
3.6 Transcatheter Heart Valves - Ongoing Clinical Trials

4 Transcatheter Heart Valves - Pipeline Products under Development by Companies
4.1 Transcatheter Heart Valves Companies - Pipeline Products by Stage of Development
4.2 Transcatheter Heart Valves - Pipeline Products by Stage of Development

5 Transcatheter Heart Valves Companies and Product Overview

6 Transcatheter Heart Valves- Recent Developments

7 Appendix
7.1 Methodology
7.2 About The Publisher
7.3 Contact Us
7.4 Disclaimer

List of Tables
  • Transcatheter Heart Valves - Pipeline Products by Stage of Development
  • Transcatheter Heart Valves - Pipeline Products by Segment
  • Transcatheter Heart Valves - Pipeline Products by Territory
  • Transcatheter Heart Valves - Pipeline Products by Regulatory Path
  • Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
  • Transcatheter Heart Valves - Ongoing Clinical Trials
  • Transcatheter Heart Valves Companies - Pipeline Products by Stage of Development
  • Transcatheter Heart Valves - Pipeline Products by Stage of Development
  • Glossary

List of Figures
  • Transcatheter Heart Valves - Pipeline Products by Stage of Development
  • Transcatheter Heart Valves - Pipeline Products by Segment
  • Transcatheter Heart Valves - Pipeline Products by Territory
  • Transcatheter Heart Valves - Pipeline Products by Regulatory Path
  • Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
  • Transcatheter Heart Valves - Ongoing Clinical Trials
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • 3DT Holdings LLC
  • 4C Medical Technologies Inc
  • Abbott Vascular Inc
  • Aegis Surgical Limited
  • Affluent Medical SA
  • Anchorvalve
  • Annulon
  • Anteris Technologies Ltd
  • AorTx, Inc.
  • Arbor Surgical Technologies, Inc.
  • Atlas Medical
  • AVVie GmbH
  • Biotronik AG
  • Boston Children's Hospital
  • Boston Scientific Corp
  • CardioMech AS
  • Cardiovalve Ltd
  • Carena Healthcare Ltd
  • Cephea Valve Technologies, Inc.
  • Chengdu Silara Meditech Inc
  • Colibri Heart Valve LLC
  • coramaze technologies GmbH
  • Daidalos Solutions BV
  • Direct Flow Medical Inc (Inactive)
  • DSM Dyneema BV
  • Dura LLC
  • Edwards Lifesciences Corp
  • Emory University
  • Endoluminal Technology Research LLC
  • Enlight Medical Technologies (Shanghai) Co Ltd
  • Florida International University
  • Folda LLC
  • Foldax Inc
  • Half Moon Medical Inc
  • Hangzhou DeJin Medtech Co Ltd
  • Hangzhou Valued Medtech Co Ltd
  • HighLife SAS
  • HLT, Inc.
  • InnovHeart SRL
  • JC Medical, Inc.
  • JenaValve Technology GmbH
  • Kekai Life Sciences
  • LaPlace Interventional Inc
  • LivaNova PLC
  • Mayo Clinic
  • Medfree Inc
  • Medtentia International Ltd Oy
  • Medtronic Plc
  • Meril Life Sciences Pvt Ltd
  • Micro Interventional Devices, Inc.
  • MicroPort CardioFlow Medtech Corp
  • MicroPort Scientific Corp
  • Mitral Heal
  • Mitralix Ltd.
  • MitrAssist Ltd.
  • Mitria Medical LLC
  • MValve Technologies Ltd.
  • NaviGate Cardiac Structures, Inc.
  • Neochord Inc
  • Neovasc Inc
  • NewMed Medical Co Ltd
  • Ningbo Jenscare Biotechnology Co Ltd
  • North Carolina State University
  • NVT AG
  • Open Stent Solution
  • Opsens Inc
  • OrbusNeich P&F
  • P+F Products + Features GmbH
  • Peca Labs Inc
  • Peijia Medical Ltd
  • Pipeline Medical Technologies Inc
  • Polares Medical SA
  • PolyNova Cardiovascular Inc
  • Polyvascular Corp
  • RegenaGraft
  • ReValve Med Inc
  • RUA Life Sciences Plc
  • SAS Cormove
  • Shanghai Hanyu Medical Technology Co Ltd
  • Shanghai Healing Medical Instruments Co Ltd
  • Sino Medical Sciences Technology Inc
  • St. Jude Medical LLC
  • Stony Brook University
  • Strait Access Technologies (Pty) Ltd
  • Symetis SA
  • The University of British Columbia
  • Thubrikar Aortic Valve, Inc.
  • Tioga Medical Inc
  • Trinity College Dublin
  • Trisol Medical Ltd
  • University College London
  • University of California
  • University of California San Francisco
  • University of Cambridge
  • University of Iowa
  • University of Pennsylvania
  • Valcare Medical
  • VALFIX Medical Ltd
  • Valtech Cardio Ltd
  • Vascudyne Inc
  • Vascular Concepts Ltd
  • Venus MedTech
  • Vesalius Cardiovascular Inc
  • Vvital Biomed Ltd
  • Xeltis AG
  • Youngheartvalve LLC
Note: Product cover images may vary from those shown